Page URL: https://www.bionews.org.uk/0044
CONTENTS Issue #44
COMMENT
Regulating gene therapy
NEWS DIGEST
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 


Visit the BioNews website at www.bionews.org.uk where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Regulating gene therapy
7 February 2000 - by Juliet Tizzard
News this week from the US that failed gene therapy trials are not being reported as required, has prompted concerns about the regulatory structures surrounding gene therapy. Reporters at the Washington Post came across reports of hundreds of failed gene therapy experiments which had not previously been sent to the... [Read More]
Testicular cancer gene located
7 February 2000 - by BioNews
A ten year international collaboration led by three British cancer charities is homing in on a gene involved in testicular cancer, known as TGCT1. Testicular germ-cell cancer is the commonest cancer among young men in Western Europe and its incidence is on the increase worldwide. Men who inherit the mutant... [Read More]
Hundreds of gene therapy experiments failed
7 February 2000 - by BioNews
Hundreds of failed gene therapy experiments, including a number of deaths, came to light in the US this week. The reports flooded in to the US National Institutes of Health (NIH), after they asked researchers to provide information that might explain the death of Jesse Gelsinger during a gene therapy... [Read More]
Japan may allow human stem cell research
7 February 2000 - by BioNews
Human embryo stem cell research is now a step closer to becoming legal in Japan. The Council for Science and Technology (CST), Japan's main science policy-making body, are expected to submit a proposal to the government in favour of research on human embryonic stem cells around the end of March... [Read More]
Some animals may be 'unclonable'
7 February 2000 - by BioNews
US researchers working on mice have reported that some animals may be 'unclonable' because of their genetic make-up. Their findings, reported in this month's Nature Genetics, show that some strains of mice may have more clone-friendly genes than others. 'We didn't expect it, but we found tremendous variability', said William... [Read More]
British biotech boom
7 February 2000 - by BioNews
The last few weeks have seen a surge of interest in British biotech firms, say Telegraph business news writers. Among those benefiting in the UK are Cambridge Antibody Technology, which makes antibodies for research and therapeutic use. Oxford Biomedica, which is developing gene therapy treatments for cancer, has also seen... [Read More]
International GMO agreement reached
7 February 2000 - by BioNews
Negotiators from 130 countries last week agreed on a Biosafety Protocol, designed to control the trade in genetically modified organisms (GMOs). It covers food, animal feed and seeds, but not pharmaceuticals. The treaty - to be called the Cartagena Protocol - allows countries to halt imports of GMOs they fear 'may have... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at snorcross@progress.org.uk

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX